BlackRock’s Milestone Scientific MLSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21K | Hold |
65,453
| – | – | ﹤0.01% | 5355 |
|
|
2026
Q1 | $18.9K | Sell |
65,453
-5,365
| -8% | -$1.5K | ﹤0.01% | 5313 |
|
|
2025
Q4 | $19.3K | Hold |
70,818
| – | – | ﹤0.01% | 5225 |
|
|
2025
Q3 | $32.2K | Hold |
70,818
| – | – | ﹤0.01% | 5058 |
|
|
2025
Q2 | $45.1K | Buy |
70,818
+287
| +0.4% | +$263 | ﹤0.01% | 5005 |
|
|
2025
Q1 | $65.8K | Hold |
70,531
| – | – | ﹤0.01% | 4863 |
|
|
2024
Q4 | $67.7K | Hold |
70,531
| – | – | ﹤0.01% | 4874 |
|
|
2024
Q3 | $64.2K | Hold |
70,531
| – | – | ﹤0.01% | 4759 |
|
|
2024
Q2 | $48.2K | Hold |
70,531
| – | – | ﹤0.01% | 4870 |
|
|
2024
Q1 | $43.9K | Hold |
70,531
| – | – | ﹤0.01% | 4899 |
|
|
2023
Q4 | $48.7K | Hold |
70,531
| – | – | ﹤0.01% | 4972 |
|
|
2023
Q3 | $64.9K | Sell |
70,531
-21,798
| -24% | -$23K | ﹤0.01% | 4955 |
|
|
2023
Q2 | $80.4K | Sell |
92,329
-102,827
| -53% | -$92.6K | ﹤0.01% | 4984 |
|
|
2023
Q1 | $176K | Sell |
195,156
-6,082
| -3% | -$4.45K | ﹤0.01% | 4813 |
|
|
2022
Q4 | $96.6K | Buy |
201,238
+2,603
| +1% | +$1.69K | ﹤0.01% | 5054 |
|
|
2022
Q3 | $157K | Sell |
198,635
-3,772
| -2% | -$3.66K | ﹤0.01% | 5043 |
|
|
2022
Q2 | $186K | Sell |
202,407
-1,243
| -0.6% | -$1.27K | ﹤0.01% | 5053 |
|
|
2022
Q1 | $310K | Sell |
203,650
-6,853
| -3% | -$10K | ﹤0.01% | 5004 |
|
|
2021
Q4 | $433K | Buy |
210,503
+12,151
| +6% | +$26.7K | ﹤0.01% | 4910 |
|
|
2021
Q3 | $371K | Buy |
198,352
+116,045
| +141% | +$215K | ﹤0.01% | 4838 |
|
|
2021
Q2 | $202K | Sell |
82,307
-2,390,520
| -97% | -$5.8M | ﹤0.01% | 4891 |
|
|
2021
Q1 | $8.83M | Buy |
2,472,827
+361,751
| +17% | +$1.24M | ﹤0.01% | 3650 |
|
|
2020
Q4 | $4.47M | Buy |
2,111,076
+302,291
| +17% | +$532K | ﹤0.01% | 3761 |
|
|
2020
Q3 | $2.52M | Sell |
1,808,785
-8,042
| -0.4% | -$14K | ﹤0.01% | 3841 |
|
|
2020
Q2 | $3.54M | Buy |
1,816,827
+1,808,607
| +22,003% | +$3.31M | ﹤0.01% | 3655 |
|
|
2020
Q1 | $10K | Buy |
8,220
+570
| +7% | +$1.03K | ﹤0.01% | 4712 |
|
|
2019
Q4 | $11K | Buy |
7,650
+129
| +2% | +$153 | ﹤0.01% | 4731 |
|
|
2019
Q3 | $6K | Buy |
7,521
+413
| +6% | +$250 | ﹤0.01% | 4769 |
|
|
2019
Q2 | $3K | Buy |
7,108
+563
| +9% | +$205 | ﹤0.01% | 4870 |
|
|
2019
Q1 | $2K | Buy |
6,545
+465
| +8% | +$171 | ﹤0.01% | 4834 |
|
|
2018
Q4 | $2K | Buy |
6,080
+577
| +10% | +$309 | ﹤0.01% | 4836 |
|
|
2018
Q3 | $4K | Sell |
5,503
-5,928
| -52% | -$4.72K | ﹤0.01% | 4830 |
|
|
2018
Q2 | $9K | Sell |
11,431
-43,883
| -79% | -$34.2K | ﹤0.01% | 4760 |
|
|
2018
Q1 | $39K | Sell |
55,314
-1,117
| -2% | -$1.08K | ﹤0.01% | 4469 |
|
|
2017
Q4 | $67K | Buy |
56,431
+2,292
| +4% | +$2.7K | ﹤0.01% | 4394 |
|
|
2017
Q3 | $67K | Sell |
54,139
-2,428
| -4% | -$3.17K | ﹤0.01% | 4430 |
|
|
2017
Q2 | $85K | Buy |
56,567
+21,118
| +60% | +$29.5K | ﹤0.01% | 4431 |
|
|
2017
Q1 | $48K | Buy |
+35,449
| New | +$49.6K | ﹤0.01% | 4472 |
|
Other funds holding MLSS
CIC
SFA
KAS
RCM
DIGI
DSAM
BlackRock's MLSS Position: Q2 2026 in Review
BlackRock held its Milestone Scientific (MLSS) position steady in Q2 2026 at 65,453 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #5355.
BlackRock first reported a position in MLSS in Q1 2017 and has held it in 38 quarters since. The position peaked at $8.83M in Q1 2021. 12 funds tracked by Wall St. Rank hold MLSS as of Q2 2026.
- BlackRock held 65,453 shares of Milestone Scientific worth $21K as of Q2 2026.
- BlackRock left its Milestone Scientific share count unchanged in Q2 2026.
- Milestone Scientific made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5355 holding.
- BlackRock first reported a position in Milestone Scientific in Q1 2017 and has held it in 38 quarters since.
- BlackRock's Milestone Scientific position peaked at $8.83M in Q1 2021.
- 12 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.